Table 2.
Group | ||||
---|---|---|---|---|
| ||||
ADHD | Control | F | η 2 p | |
Short-term memory | ||||
# Correct Trials FWD | 4.34 (1.74) | 5.55 (1.91) | 14.687** | 0.062 |
# Correct Trials BK | 3.66 (1.95) | 4.65 (2.09) | 8.170** | 0.025 |
Psychophysiology data | ||||
Resting RSA | 7.52 (1.11) | 7.21 (1.17) | 4.072 | 0.015 |
Neutral baseline RSA | 7.08 (1.28) | 6.70 (1.32) | 6.787* | 0.028 |
SSp Fwd RSA 30seca | 7.28 (1.18) | 6.85 (1.22) | 6.454* | 0.027 |
SSp Bkw RSA 30seca | 7.20 (1.17) | 6.84 (1.20) | 5.999* | 0.025 |
ΔRSA SSp FWDb | 0.20 (0.97) | 0.15 (0.83) | 0.122 | 0.001 |
ΔRSA SSp BKb | 0.12 (0.93) | 0.15 (0.80) | 0.289 | 0.001 |
All analyses covaried for gender, age, ODD symptoms, and stimulant use status.
p<0.05.
p<0.01. η2 p, Partial Eta-squared
Mean RSA during the first 30-s epoch
Change from neutral baseline condition